Microfluidics: the propellant of CRISPR-based nucleic acid detection

Area of Science:

• Biotechnology
• Molecular Biology
• Diagnostics

Background:

• Clustered regularly interspaced short palindromic repeats (CRISPR)/Cas systems are powerful nucleic acid detection tools due to their collateral cleavage activity.
• Current CRISPR applications are limited by the need for pre-amplification steps, which reduce sensitivity and quantitative precision.
• Nonspecific collateral activity hinders multiplex detection in single-pot CRISPR reactions using a single Cas protein.

Purpose of the Study:

• To address the limitations of CRISPR systems for nucleic acid detection.
• To explore the integration of microfluidics with CRISPR technology.
• To enhance the sensitivity, speed, and multiplexing capabilities of CRISPR-based detection.

Main Methods:

• Investigated the synergistic effects of combining microfluidics with CRISPR/Cas systems.
• Focused on overcoming challenges associated with pre-amplification requirements and nonspecific collateral activity.
• Utilized microfluidic platforms for miniaturization, integration, and automation of nucleic acid analysis.

Main Results:

• Microfluidics coupled with CRISPR systems significantly improves detection sensitivity.
• The integrated approach enables fast, high-throughput, and automated nucleic acid detection.
• Demonstrated the potential for multiplex detection and digital readout within a single microfluidic chip.

Conclusions:

• The integration of microfluidics and CRISPR technology overcomes key limitations in nucleic acid detection.
• This combination facilitates rapid, sensitive, and multiplexed detection, expanding CRISPR's applicability.
• Microfluidic-CRISPR systems pave the way for widespread adoption in diverse diagnostic and research scenarios.